关于“东北制药”的报告
艾媒咨询|2021H1中国智能制造专题研究报告
本报告研究涉及企业/品牌/案例：深兰科技，依图科技，远望谷
iiMedia Research(艾媒咨询)数据显示，2020年全国工业软件市场规模达到1974亿元;2020年中国智能硬件市场规模达到10747亿元，同比增长67.1%。随着工业互联网的规模进一步扩大和公有云和信息传输技术的发展，中国制造业智能化将蓬勃发展。其次，智能制造应用场景广阔，赋能汽车、钢铁、3C电子、医疗等行业。 iiMedia Research(艾媒咨询)数据显示，随着技术改革的推动，我国3C电子智能制造业规模2022年将达到5.47万亿元。目前，从生产流程的覆盖率看，我国3C电子智能制造业自动化渗透率仅为20-30%。艾媒咨询分析师认为，智能制造将进一步推动汽车、钢铁、3C电子、医疗等行业数字化、智能化改革，从而释放相关行业的产能。此外，受益于国家政策的大力推动，更多的企业进行研发、生产和投资智能制造装备，形成了智能制造装备产业体系。以数据为基础，智能制造将实现产品设计等全过程的自动化、集成化、信息化，满足产品的个性化、定制化的需求。
As to the data of iiMedia Research, in 2020, the scale of China's industrial software market will reach 1974 billion RMB and the scale of China's intelligent hardware market will reach 1074.7 billion RMB, with a year-on-year growth of 67.1%. With the further expansion of the scale of industrial Internet and the development of public cloud and information transmission technology, China's intelligent manufacturing industry will flourish. Secondly, intelligent manufacturing has broad application scenarios, enabling automobile, steel, 3C electronics, medical and other industries. As to the data of iiMedia Research, with the promotion of technological reform, the scale of 3C electronic intelligent manufacturing industry in China will reach 5.47 trillion RMB in 2022. From the perspective of production process coverage, the penetration rate of 3C electronic intelligent manufacturing automation in China is only 20-30%. The consulting analyst of iiMedia Research believes that intelligent manufacturing will further promote the digital and intelligent reform of automobile, steel, 3C electronics, medical and other industries and release the production capacity of related industries. In addition, benefiting from the strong promotion of national policies, more enterprises carry out R & D, production and investment in intelligent manufacturing equipment, forming an intelligent manufacturing equipment industry system. Based on data, intelligent manufacturing will realize the automation, integration and informatization of the whole process of product design, so as to meet the personalized and customized needs of products.-
艾媒咨询|2021全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例：阿里健康，联合丽格，恒瑞医药，白云山，平安好医生，111集团，新氧，药明巨诺，盘龙药业，先导药业，好大夫在线，优健康，春雨医生，丁香医生，微医
受到人口老龄化、居民患病比例增加等因素影响，国家医疗费用支出不断增加，属于刚性需求；同时，随着人们对健康标准的不断提高以及互联网医疗技术的发展，大健康产业会在相当长的时期内持续保持增长态势。数据显示，2020年中国的大健康产业营收规模超过7万亿元，预计2021年将达8万亿元，增幅达8.1%。其中，得益于大健康产业发展以及疫情期间医药需求增长，生物制药、医疗器械两大细分领域表现良好，成为2020年中国投资热度较高的新经济行业，投资项目金额分别为919亿元和273亿元。
Affected by the aging population and the increasing proportion of residents, the national medical expenditure is increasing, which belongs to the rigid demand; At the same time, with the continuous improvement of people's health standards and the development of internet medical technology, the big health industry will continue to grow for a long time. According to the data, the revenue of China's big health industry will exceed 7 trillion yuan in 2020, and it is expected to reach 8 trillion yuan in 2021, an increase of 8.1%. Among them, thanks to the development of big health industry and the growth of pharmaceutical demand during the epidemic period, biopharmaceuticals and medical devices have performed well, becoming China's new economy industry with high investment enthusiasm in 2020, with investment projects of 91.9 billion yuan and 27.3 billion yuan respectively. -
艾媒咨询|2020年第三季度中国中药材行业数据监测季度报告
本报告研究涉及企业/品牌/案例：同仁堂、香雪制药、白云山。
数据显示，2020年第三季度，中药材价格指数迎来上涨周期。艾媒咨询分析师认为，受动物类等少数品种拉动影响，预计2020年10-11月中药材指数会持续走高，但是在12月维稳。据调查，绝大多数商户将会在2021年密切关注行业相关政策、谨慎经营，采取减少压货炒作等经营方式。因而，预计中药材市场在2020年末旺季会有一波行情的走高，但随着旺季结束，明年年初的价格会重新回落，随着疫情的常态化，中药材市场行情预期会呈周期性波动的态势。
Data show that in the third quarter of 2020, Chinese Herbal Medicine Price Index ushered in an upward cycle. iiMedia Research believe that by a small number of animals and other species pull the impact of October 2020-november Chinese herbal medicine index is expected to continue to rise, but stable in December. According to the survey, the vast majority of businesses in the 2021 will pay close attention to industry-related policies, prudent management, to reduce speculation and other business practices. As a result, the Chinese herbal medicine market is expected to see a wave of rising prices in the peak season at the end of 2020. However, as the peak season ends, prices will fall back early next year, and as the epidemic becomes more normal, chinese medicinal materials market is expected to be cyclical fluctuations in the situation. -
艾媒报告|2020年全球消毒杀毒产品市场分析及发展趋势报告
本报告研究涉及企业/品牌/案例：老肯医疗，新华医疗，威莱，三友化工；
其他提及企业/品牌：滴露，威露士，蓝月亮，洗得宝，威猛先生，如辉，巨光，海氏海诺，威王，净安，优露清，利尔康，安洁，威洁士，欧洁，仁和，泰和科技，京汉股份，比亚迪，仁瑞生物科技，盘龙药业，东北制药等。
2020年4月28日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年全球消毒杀毒产品市场分析及发展趋势报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对全球消毒杀毒产品进行全面分析，并且通过对三友化工、威莱集团（威尔士）、新华医疗和老肯医疗的典型企业案例分析，特别结合新冠疫情影响下消毒杀毒用品的用户调研，判断2020-2021年全球消毒杀毒行业发展趋势。随着经济环境和人民生活水平不断改善，国家对于医疗卫生更加重视，卫生投入不断增加，医疗机构数量显著增长，居民的卫生健康意识也持续提高，从需求端拉动消毒产品行业发展。特别在新冠疫情影响下，消毒杀毒产品的需求量骤升，其中小包装的消杀产品需求量特别大，短期消杀用品存在供需结构矛盾。
In 2020, the national medical institutions and other public places need large-scale, long-term, high-frequency disinfection, in addition, the public awareness of home disinfection has also given birth to a huge demand for disinfection products. According to iiMedia Research, the new crown outbreak in 2020 has had an impact on the purchase of disinfection products by 84% of consumers, with the market value of disinfection products expected to reach 38.26 billion yuan for the full year. -
-
-
-
-
-
- 1
- 2
- 3
